Emma Du Four has extensive global experience in the biopharmaceutical industry encompassing product development, clinical trials, real world evidence, paediatric medicines, biotherapeutics, devices, pharmacovigilance, policy and strategy development. Emma currently serves as Head of International Regulatory Policy at AbbVie, where she is responsible for providing strategic guidance and leadership on regulatory policy issues. Emma holds an Honours degree in BioChemistry, an MBA and is a Fellow of The Organisation for Professionals in Regulatory Affairs (TOPRA)